Skip to main content

Main menu

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Institutional open access agreements
    • Peer reviewer login
    • WoS Reviewer Recognition Service
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Institutional open access agreements
    • Peer reviewer login
    • WoS Reviewer Recognition Service
  • Alerts
  • Subscriptions

Modulator treatment for people with cystic fibrosis: moving in the right direction

J. Stuart Elborn
European Respiratory Review 2020 29: 200051; DOI: 10.1183/16000617.0051-2020
J. Stuart Elborn
Faculty of Medicine Health and Life Sciences, Queens University of Belfast, Belfast, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: s.elborn@qub.ac.uk
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 29 no. 155
DOI 
https://doi.org/10.1183/16000617.0051-2020
PubMed 
32198220

Published By 
European Respiratory Society
Print ISSN 
0905-9180
Online ISSN 
1600-0617
History 
  • Received February 24, 2020
  • Accepted February 27, 2020
  • Published online March 20, 2020.

Copyright & Usage 
Copyright ©ERS 2020. This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

Author Information

  1. J. Stuart Elborn⇑
  1. Faculty of Medicine Health and Life Sciences, Queens University of Belfast, Belfast, UK
  1. J. Stuart Elborn. Faculty of Medicine Health and Life Sciences, Queens University of Belfast, 90 Lisburn Rd, Belfast, BT9 6AG, UK. E-mail: s.elborn{at}qub.ac.uk
View Full Text

Article usage

Article usage: March 2020 to November 2023

AbstractFullPdf
Mar 202014240102
Apr 2020630463
May 202019839
Jun 202026021
Jul 202036228
Aug 202026319
Sep 202039513
Oct 202008718
Nov 2020110633
Dec 2020110424
Jan 2021311229
Feb 2021512155
Mar 2021319438
Apr 2021118053
May 2021213137
Jun 2021110515
Jul 202138220
Aug 202108816
Sep 202117320
Oct 202138042
Nov 202115923
Dec 202114812
Jan 20220397
Feb 20222444
Mar 202208611
Apr 20220368
May 202214315
Jun 202202012
Jul 20220257
Aug 20222242
Sep 202203215
Oct 20220409
Nov 20222386
Dec 202204322
Jan 202313711
Feb 202304511
Mar 20231547
Apr 202312221
May 202301813
Jun 20231174
Jul 202311810
Aug 202312415
Sep 202304022
Oct 202314411
Nov 202306811

Altmetrics

PreviousNext
Back to top
View this article with LENS
Vol 29 Issue 155 Table of Contents
European Respiratory Review: 29 (155)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Modulator treatment for people with cystic fibrosis: moving in the right direction
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Modulator treatment for people with cystic fibrosis: moving in the right direction
J. Stuart Elborn
European Respiratory Review Mar 2020, 29 (155) 200051; DOI: 10.1183/16000617.0051-2020

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Modulator treatment for people with cystic fibrosis: moving in the right direction
J. Stuart Elborn
European Respiratory Review Mar 2020, 29 (155) 200051; DOI: 10.1183/16000617.0051-2020
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Footnotes
    • References
  • Info & Metrics
  • PDF

Subjects

  • CF and non-CF bronchiectasis
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Clinical and prognostic value of ventilatory efficiency in cardiorespiratory disorders
  • Guidance production before evidence generation for critical issues: COVID-19
Show more Editorial

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERR

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising
  • Sponsorship

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN: 0905-9180
Online ISSN: 1600-0617

Copyright © 2023 by the European Respiratory Society